it regulates locomotion, anxiety, and food responses including appetite, satiety, obesity, gut motility, and nausea 29,30
Patients should not discontinue statins in favour of GLP-1 therapy for cholesterol management without explicit guidance from their healthcare provider, as this could compromise cardiovascular risk reduction
Muscle loss alongside fat loss, leading to fatigue and reduced strength if protein intake and resistance training arent prioritized Digestive side effects such as nausea, bloating, and constipation, which can affect nutrition if meals are skipped rather than adjusted Weight regains after stopping the medication, since appetite-suppressing effects fade once treatment ends a pattern also discussed in Part 1s FAQ section The ongoing need for exercise and adequate protein throughout treatment, not just before or after it, to protect long-term metabolic health These medicines should not be viewed as a short-term fix
Experts stress that semaglutide works best as part of a broader treatment plan, which also includes regular physical activity and proper diet to improve both the efficacy and tolerability of the drug
The activity of the signal molecule AI-2 was highest at 14 h of incubation and then decreased with increasing incubation time
Muscle Loss and Metabolic Concerns A legitimate concern involves the composition of weight lost during semaglutide treatment